These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25260968)

  • 1. Applause sign in advanced Parkinson's disease.
    Weerkamp NJ; Tissingh G; Poels PJ; Zuidema SU; Munneke M; Koopmans RT; Bloem BR
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1268-9. PubMed ID: 25260968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The applause sign and neuropsychological profile in progressive supranuclear palsy and Parkinson's disease.
    Somme J; Gómez-Esteban JC; Tijero B; Berganzo K; Lezcano E; Zarranz JJ
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1230-3. PubMed ID: 23253819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The applause sign in Parkinson's disease patients is related to dysexecutive syndrome.
    Tomic S; Vladetic M; Solic K; Misevic S; Soldo SB
    J Clin Neurosci; 2013 Dec; 20(12):1734-6. PubMed ID: 23972562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addenbrooke's Cognitive Examination validation in Parkinson's disease.
    Reyes MA; Perez-Lloret S; Roldan Gerschcovich E; Martin ME; Leiguarda R; Merello M
    Eur J Neurol; 2009 Jan; 16(1):142-7. PubMed ID: 19049504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric attributes of the SCOPA-COG Brazilian version.
    Carod-Artal FJ; Martínez-Martin P; Kummer W; Ribeiro Lda S
    Mov Disord; 2008 Jan; 23(1):81-7. PubMed ID: 17987646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applause sign: screening utility for dementia and cognitive impairment.
    Bonello M; Larner AJ
    Postgrad Med; 2016; 128(2):250-3. PubMed ID: 26560747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of the "applause sign" in patients with amyotrophic lateral sclerosis.
    Anneser JM; Krzovska M; Borasio GD; Danek A
    Clin Neurol Neurosurg; 2015 Oct; 137():8-10. PubMed ID: 26117556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of life.
    Weerkamp NJ; Tissingh G; Poels PJ; Zuidema SU; Munneke M; Koopmans RT; Bloem BR
    J Am Geriatr Soc; 2013 Oct; 61(10):1714-21. PubMed ID: 24117286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychometric attributes of the Parkinson's Disease-Cognitive Rating Scale. An independent validation study].
    Martínez-Martín P; Prieto-Jurczynska C; Frades-Payo B
    Rev Neurol; 2009 Oct 16-31; 49(8):393-8. PubMed ID: 19816841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Applause sign" helps to discriminate PSP from FTD and PD.
    Dubois B; Slachevsky A; Pillon B; Beato R; Villalponda JM; Litvan I
    Neurology; 2005 Jun; 64(12):2132-3. PubMed ID: 15985587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical predictors of cognitive impairment and psychiatric complications in Parkinson's disease.
    Campos LS; Guimarães RP; Piovesana LG; Azevedo PC; Santos LM; D'Abreu A
    Arq Neuropsiquiatr; 2015 May; 73(5):390-5. PubMed ID: 26017203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor profile and drug treatment of nursing home residents with Parkinson's disease.
    Weerkamp NJ; Zuidema SU; Tissingh G; Poels PJ; Munneke M; Koopmans RT; Bloem BR
    J Am Geriatr Soc; 2012 Dec; 60(12):2277-82. PubMed ID: 23231550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychometric attributes of Scales for Outcomes in Parkinson's Disease-Cognition (SCOPA-Cog), Castilian language].
    Martínez-Martín P; Frades-Payo B; Rodríguez-Blázquez C; Forjaz MJ; de Pedro-Cuesta J;
    Rev Neurol; 2008 Oct 1-15; 47(7):337-43. PubMed ID: 18841543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.
    Kulisevsky J; Pagonabarraga J
    Mov Disord; 2009 Jun; 24(8):1103-10. PubMed ID: 19353727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frontal assessment battery as a tool for evaluation of frontal lobe dysfunction in patients with Parkinson disease.
    Cohen OS; Vakil E; Tanne D; Molshatzki N; Nitsan Z; Hassin-Baer S
    J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):71-7. PubMed ID: 22689698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metric properties of the mini-mental Parkinson and SCOPA-COG scales for rating cognitive deterioration in Parkinson's disease.
    Serrano-Dueñas M; Calero B; Serrano S; Serrano M; Coronel P
    Mov Disord; 2010 Nov; 25(15):2555-62. PubMed ID: 20824734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of leukoaraiosis on the cognition of patients with Parkinson disease].
    Wang L; Zhu XQ; Jiang CJ; Chen XW; Sun ZW
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(3):177-81. PubMed ID: 23570589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inferior frontal region hypoperfusion in Parkinson disease with dementia].
    Ochudło S; Opala G; Jasińska-Myga B; Siuda J; Nowak S
    Neurol Neurochir Pol; 2003; 37 Suppl 5():133-44. PubMed ID: 15098340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between olfactory loss and cognitive deficits in Parkinson's disease.
    Camargo CHF; Jobbins VA; Serpa RA; Berbetz FA; Sabatini JS; Teive HAG
    Clin Neurol Neurosurg; 2018 Oct; 173():120-123. PubMed ID: 30121454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applause sign in Parkinsonian disorders and Huntington's disease.
    Wu LJ; Sitburana O; Davidson A; Jankovic J
    Mov Disord; 2008 Dec; 23(16):2307-11. PubMed ID: 18972544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.